Attorney:
Sameer Gokhale
April 29, 2025
On April 18, 2025, the Court of Appeals for the Federal Circuit issued a precedential decision relating to a question of whether claims that do no more than apply established methods of machine learning to a new data environment are patent eligible. A copy of the decision can be found here.<... Read more
Attorney:
Sameer Gokhale
July 22, 2024
The U.S. Patent and Trademark Office (USPTO) has issued an update to the guidance on patent subject matter eligibility to address artificial intelligence (AI). This update provides further clarity and consistency on how the USPTO and applicants should evaluate subject matter eligibility of claims in patent applications and patents involving inventions related to AI technology. The guidance update also announces three new examples of how to apply this guidance through a few key technologies. <... Read more
Attorney:
Sameer Gokhale
December 13, 2022
In the Federal Circuit decision in Amgen Inc. v. Sanofi[1], while invalidating two of Amgen’s antibody patents, the CAFC made the following statement regarding the enablement requirement of 35 U.S.C. §112.<... Read more
Attorney:
Kurt M. Berger, Ph.D.
August 16, 2022
The Federal Circuit recently affirmed a decision in the Eastern District of Virginia holding that the Patent Act unambiguously requires an inventor to be a natural person.<... Read more
Attorney:
Yuki Onoe
April 18, 2022
Support Vector Machine-Recursive Feature Elimination (SVM-RFE) is a technology which can be used to find relevant patterns in a large data set such as the data generated in the sequencing of genomes and produce smaller subsets. In Health Discovery Corp. v. Intel Corp.[1], the patent owner HDC, in its complaint for infringement, discussed the innovative aspects of the technology:<... Read more